- Home
- MTCH vs KYMR Comparison
MTCH vs KYMR Comparison
Compare MTCH & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTCH | KYMR |
|---|---|---|
| Founded | 1986 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 10.6B |
| IPO Year | 2004 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MTCH | KYMR |
|---|---|---|
| Price | $41.78 | $119.36 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 26 |
| Target Price | $35.17 | ★ $107.72 |
| AVG Volume (30 Days) | ★ 3.3M | 649.1K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.16% | N/A |
| EPS Growth | ★ 17.82 | N/A |
| EPS | ★ 1.37 | N/A |
| Revenue | ★ $3,487,197,000.00 | $39,211,000.00 |
| Revenue This Year | $2.15 | $10.61 |
| Revenue Next Year | $3.82 | $8.17 |
| P/E Ratio | $29.67 | ★ N/A |
| Revenue Growth | ★ 0.22 | N/A |
| 52 Week Low | $28.81 | $40.10 |
| 52 Week High | $42.49 | $130.05 |
Technical Indicators
Market Signals| Indicator | MTCH | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 60.61 | 52.58 |
| Support Level | $37.19 | $108.87 |
| Resistance Level | $42.49 | $120.37 |
| Average True Range (ATR) | 1.16 | 4.70 |
| MACD | 0.21 | -0.55 |
| Stochastic Oscillator | 87.13 | 42.92 |
Price Performance
Historical ComparisonAbout MTCH Match Group Inc.
Match Group Inc is a provider of online dating products. The company's portfolio of brands includes Tinder, Hinge, Match, Meetic, OkCupid, Pairs, Plenty Of Fish, Azar, BLK, and more, each built to increase its user's likelihood of connecting with others. The company has four operating segments: Tinder, Hinge, Evergreen and Emerging, and Match Group Asia. It generates the majority of its revenue from the Tinder segment.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.